Physician profile
Ashley Barham
NPI 1396113296
$2,223.58
in general payments reported to CMS, 2019-2025
20 companies · $948 in 2025
The $948 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $244 · 2024: $928 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,119.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $935.21 | 2022-2025 | |
| Pfizer INC. | $433.13 | 2023-2025 | |
| Lundbeck LLC | $243.95 | 2023-2025 | Vyepti |
| Impel Pharmaceuticals LLC | $145.75 | 2024-2025 | Trudhesa |
| Lilly USA, LLC | $67.77 | 2023-2024 | Emgality, Reyvow |
| Merz Pharmaceuticals, LLC | $55.76 | 2024-2025 | Xeomin |
| Teva Pharmaceuticals USA, INC. | $43.47 | 2025 | Ajovy |
| Axsome Therapeutics, INC. | $40.82 | 2025 | Symbravo |
| Idorsia Pharmaceuticals US INC | $38.40 | 2024 | Quviviq |
| Tonix Medicines, INC. | $33.11 | 2025 | Zembrace Symtouch |
| Amgen INC. | $29.54 | 2024 | Aimovig |
| Amneal Pharmaceuticals LLC | $23.96 | 2025 | Brekiya |
| Nestle Healthcare Nutrition INC. | $20.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.21 | 2024 | Nuedexta |
| Alkermes, INC. | $17.34 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $17.27 | 2022 | |
| Collegium Pharmaceutical, INC. | $16.68 | 2023 | Xtampza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.10 | 2022 | |
| Merck Sharp & Dohme LLC | $13.02 | 2023 | Belsomra |
| Vanda Pharmaceuticals INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Barham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.